Breaking Down Jiangxi Zhengbang Technology Co.Ltd. Financial Health: Key Insights for Investors

Jiangxi Zhengbang Technology Co., Ltd. (002157.SZ) is at a turning point: Q3 2025 revenue jumped to CNY 3.82 billion (up 46.11% YoY) and TTM revenue reached CNY 13.69 billion (a staggering 94.37% YoY growth), fueled by a pig farming surge-first-half 2025 pig farming revenue of CNY 4.077 billion after live pig sales rose 125.04% to 3.5766 million heads and average price gains of ~CNY 46/head; simultaneously the company returned to profit with Q1 2025 net income of CNY 170.6 million amid a gross margin of 14.38% (+190.28% YoY) and EBITDA margin of 7.72% (+124.46% YoY), while balance-sheet repair shows total liabilities down to CNY 8.717 billion in Q1 2025, an asset-liability ratio of 44.91% and a conservative debt-to-equity of 0.16 after a CNY 4.34 billion strategic injection from Jiangxi Twins Agriculture-yet investors must weigh valuation metrics (market cap CNY 32.89 billion; P/S 2.08; EV/EBITDA 30.99; EV/FCF 78.57), liquidity constraints (current ratio 1.09; quick ratio 0.64; interest coverage 1.06) and sector risks like disease and price volatility against growth plans to produce over 7 million market-ready hogs in 2025 and projected 10-12% annual revenue growth-read on to dive into the detailed numbers, segment dynamics, risks and valuation drivers that matter for investors.}

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Revenue Analysis

Jiangxi Zhengbang Technology Co.Ltd. reported robust top-line expansion across 2024-2025, driven predominantly by a surge in its pig farming operations and higher average selling prices for live pigs. Key headline figures and segment drivers are summarized below.

• Q3 (quarter ending Sep 30, 2025) revenue: CNY 3.82 billion (+46.11% YoY).
• Trailing twelve months (TTM) revenue as of Sep 30, 2025: CNY 13.69 billion (+94.37% YoY).
• Full-year 2024 revenue: CNY 8.87 billion (+26.86% YoY vs. 2023).
• First half 2025 pig farming revenue: CNY 4.077 billion (+134.59% YoY).
• Live pig sales H1 2025: 3.5766 million heads (+125.04% YoY) with an average price increase of ~CNY 46 per head.
• Revenue per employee: ~CNY 1.76 million based on 7,780 employees.

The pig farming segment is the primary growth engine: higher volumes (3.5766 million heads in H1 2025) combined with improved selling prices drove a >134% increase in segment revenue for the first half of 2025. This operational leverage is reflected in the near-doubling of TTM revenue versus the prior year.

• Volume driver: +125.04% YoY increase in live pig sales (H1 2025).
• Price driver: average price up ~CNY 46 per head, amplifying revenue per head.
• Operational efficiency: revenue per employee ≈ CNY 1.76 million supports capital-light scaling in husbandry and downstream operations.

For broader context on the company's history, ownership and business model, see Jiangxi Zhengbang Technology Co.Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) Profitability Metrics

• Net profit (Q1 2025): CNY 170.6 million - first profitable quarter after earlier losses.
• Gross profit margin: 14.38%, up 190.28% year-over-year - indicates meaningful margin recovery.
• EBITDA margin: 7.72%, up 124.46% year-over-year - shows stronger core-operating performance.
• Operating income growth (Q1 2025): +108% year-over-year - significant turnaround in topline operations.
• Previous full-year net loss (2023): CNY 5.9 billion - underscores severity of prior challenges.
• ROE: -2.26% - equity returns still negative, reflecting legacy losses and capital structure effects.
• ROIC: 1.34% - positive but modest returns on invested capital, showing early-stage recovery.

• Drivers of improvement: margin recovery suggests better input cost management, pricing adjustments, and operating leverage.
• Risks remaining: legacy losses (CNY 5.9bn in 2023) still weigh on equity returns and balance sheet strength.
• What to watch next: sustainability of gross margin >10%, continued EBITDA margin expansion, and sequential improvements in ROIC and ROE.

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Debt vs. Equity Structure

• Total liabilities fell to CNY 8.717 billion as of Q1 2025, contrasting sharply with the CNY 34.83 billion peak in 2022.
• Asset-liability ratio improved to 44.91% in Q1 2025, down from 148.38% in 2022.
• Debt-to-equity ratio of 0.16 (Q1 2025) signals low financial leverage and a conservative balance-sheet stance.
• Short-term liquidity: current ratio 1.09 and quick ratio 0.64 (Q1 2025), indicating adequate working-capital coverage though reliance on inventory and receivables remains material.
• Key external support included CNY 4.34 billion in funding from Jiangxi Twins Agriculture Co., Ltd. in 2023, which materially aided restructuring.

• The near‑seven percentage‑point reduction to a 47.05% asset‑liability ratio by Q3 2024 reflects active deleveraging and liability restructuring prior to the continued improvement into Q1 2025.
• External strategic equity/funding injections (notably CNY 4.34 billion in 2023) were pivotal in converting distressed leverage into a stable capital base.
• Lower debt levels and a 0.16 debt‑to‑equity ratio materially reduce interest and refinancing risk, improving resilience to cash‑flow volatility.

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Liquidity and Solvency

• Current ratio: 1.09 - sufficient short-term assets to meet current liabilities, but only marginally above the 1.0 threshold.
• Quick ratio: 0.64 - indicates potential strain if inventory cannot be converted quickly into cash to meet immediate obligations.
• Interest coverage ratio: 1.06 - operating income covers interest expense by a slim margin, signaling limited buffer against earnings volatility.
• Debt-to-EBITDA: 1.68 - moderate leverage, suggesting debt is manageable relative to operating earnings.
• Debt-to-free cash flow: 4.26 - the company generates sufficient free cash flow to service debt, though this ratio implies multiple years of FCF would be needed to fully retire outstanding debt at current levels.
• Total liabilities: CNY 8.717 billion (Q1 2025) - a significant reduction from prior periods, improving solvency metrics and creditor confidence.

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Valuation Analysis

• Market capitalization: CNY 32.89 billion - reflects current market valuation and scale.
• Price-to-Sales (P/S): 2.08 - market values each yuan of revenue at just over two yuan of equity value.
• EV/EBITDA: 30.99 - indicates the enterprise is trading at a high multiple of operating earnings.
• EV/FCF: 78.57 - shows enterprise value is large relative to free cash flow generation, signaling stretched valuation versus cash returns.
• 52-week price change: +13.55% - positive momentum over the past year.
• Beta: 0.64 - lower volatility than the broader market, implying defensive characteristics.

• Implications for investors:
  • High EV/EBITDA and EV/FCF suggest expectations of sustained margin expansion, growth, or low perceived risk - verify through earnings and cash flow trajectory.
  • P/S around 2 implies revenue is valued but not excessively so compared with some high-growth peers; assess revenue growth rates and margins to judge fairness.
  • Beta of 0.64 and recent price appreciation indicate relative stability with upside captured by the market; risk-adjusted return expectations should account for the premium valuation.
• Key questions to validate the valuation:
  • Are EBITDA margins and FCF expected to expand sufficiently to justify EV multiples near 31 and 79?
  • What is the projected revenue growth that supports a P/S of 2.08?
  • How sensitive is the company's cash flow to commodity/input costs and policy shifts in its operating markets?

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Risk Factors

• High leverage and historical losses: the company has carried substantial borrowing to finance expansion and herd recovery, resulting in elevated interest expenses and recurring net losses in recent reporting periods.
• Disease exposure: African Swine Fever (ASF) and other swine diseases can cause near-total mortality in affected herds, trigger emergency culls, and force herd restocking delays that reduce production capacity.
• Price volatility: fluctuations in hog and pork prices materially affect revenue and margin; large price swings can quickly turn profitable quarters into losses.
• Operational inefficiencies: feed conversion rates, biosecurity lapses and herd-health management materially influence unit economics and competitiveness.
• Domestic market concentration: heavy reliance on the Chinese market leaves the company exposed to local demand shifts, consumer-price sensitivity and regulatory changes.
• Solvency and liquidity risk: persistent losses combined with high debt raise the probability of covenant pressure, refinancing difficulty and constrained working capital.

• Balance-sheet sensitivity: with high financial leverage, small revenue declines or margin compressions can lead to rapid deterioration in interest-coverage ratios and free-cash-flow generation.
• Refinancing risk: rollovers of bank loans or bond maturities could require higher rates or equity injections if operating performance does not improve.
• Supply-chain and biosecurity costs: maintaining strict biosecurity and insurance increases operating expense; failure to control disease outbreaks can produce one-time and ongoing losses.
• Regulatory and policy risk: meat supply interventions, price-controls, environmental and animal-welfare regulations in China can impose unexpected compliance costs or restrict operations.

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) - Growth Opportunities

Jiangxi Zhengbang Technology Co.Ltd. (002157.SZ) is positioning itself to capture China's expanding pork market through scale, technology, and integrated operations. Key drivers and tangible metrics underpinning the growth thesis are summarized below.

• Scale target: produce over 7,000,000 market-ready hogs in 2025 to align with rising domestic pork demand and industry consolidation.
• R&D commitment: reported a 33% increase in R&D investment in 2023, signaling intensified focus on breeding, feed efficiency, disease control and digital farm technologies.
• Strategic funding: partnership with Twins Group delivering a total investment of CNY 4.34 billion to support capacity expansion and balance-sheet recovery.
• Cost and operational improvements: fattening pig cost reduced to CNY 13.3 per kilogram by March 2025, improving gross margin potential across production cycles.
• Top-line outlook: management projects an annual revenue growth rate of 10-12% over the next five years, driven by capacity, product mix upgrades and tech-driven productivity gains.
• Integrated model advantages: feed production, pig farming and veterinary services enable cross-segment synergies-reducing input costs, improving animal health and accelerating time-to-market.

• Operational levers: scale-up of breeding farms, optimized feed formulas from in-house R&D, tighter biosecurity and centralized procurement to sustain the CNY 13.3/kg cost target and margin expansion.
• Financial levers: deployment of CNY 4.34 billion strategic investment to shore up liquidity, fund capex and accelerate deleveraging-critical for funding the >7 million hogs target without disrupting operating cash flow.
• Commercial levers: product mix improvement and veterinary services create premium/added-value offerings to lift ASPs (average selling prices) and reduce mortality, supporting the projected 10-12% revenue CAGR.

Additional context and investor-focused details are available here: Exploring Jiangxi Zhengbang Technology Co.Ltd. Investor Profile: Who's Buying and Why?